Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD |
Young Investigator Grants |
2023 |
Texas |
Adoptive Cell Therapy Targeting Antigen Escape Variants in Childhood High Grade Glioma |
Baylor College of Medicine / Meenakshi Hegde |
Young Investigator Grants |
2012 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma |
Baylor College of Medicine / Kyle Eagen, PhD |
R Accelerated Award Grants |
2022 |
Texas |
Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence |
Baylor College of Medicine / Stacey Berg, MD - Scholars: Holly Lindsay, MD/MS, Sarah Injac, MD |
Center of Excellence Grants |
2012 |
Texas |
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma |
Baylor College of Medicine / Andras Heczey, MD |
Bio-Therapeutic Impact Award |
2017 |
Texas |
High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy |
Baylor College of Medicine / Xavier Rios, MD/PhD |
Young Investigator Grants |
2020 |
Texas |
Mechanisms of LYL1-associated T-ALL development |
Baylor College of Medicine / Margaret Goodell, PhD |
Innovation Grants |
2012 |
Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |